Litcius/Paper detail

CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer

Wei‐Bang Yu, Yu‐Chi Chen, Can-Yu Huang, Zi-Han Ye, Wei Shi, Hong Zhu, Jia-Jie Shi, Jun Chen, Jin-Jian Lu

2022Frontiers of Medicine12 citationsDOI

Topics & Concepts

OsimertinibBlockadeLung cancerMedicineOncologyCancerInternal medicineAdenocarcinomaReceptorROS1Phagocytosis and Immune RegulationCell death mechanisms and regulationImmunotherapy and Immune Responses
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer | Litcius